Profiel
Christopher Williams is currently the Head of Media Relations at Juno Therapeutics, Inc. and the Chief Communications Officer at Compass Pathways Plc.
He previously worked as the Vice President and Head of Corporate Communications at Sanofi SA.
Actieve functies van Christopher Williams
| Bedrijven | Functie | Begin |
|---|---|---|
| JUNO THERAPEUTICS INC | Public Communications Contact | - |
| COMPASS PATHWAYS PLC | Public Communications Contact | - |
Eerdere bekende functies van Christopher Williams
| Bedrijven | Functie | Einde |
|---|---|---|
| Sanofi SA | Public Communications Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| COMPASS PATHWAYS PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
| Sanofi SA | Health Technology |
